SCHEMBL19690601

SCHEMBL19690601

CC(C)C1CCCCC1OC(=O)CCC(=O)OC1CCCCC1C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
EPHX1 P07099 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP19A1 P11511 3/20 0.39
NAAA Q02083 2/20 0.39
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
MAPT P10636 2/20 0.36
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 2/20 0.36
SLC18A3 Q16572 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690602 0.93 LMNA (0.46) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL27622679 0.91 ALDH1A1 (0.40) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL16281717 0.89 ALDH1A1 (0.35) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL13034074 0.81 CHRM2 (0.42) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL10599769 0.79 EPHX1 (0.44) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL12377941 0.79 EPHX1 (0.41) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL16155131 0.79 ALDH1A1 (0.35) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL13558209 0.78 EPHX1 (0.40) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL13558208 0.78 EPHX1 (0.40) ALDH1A1EPHX1MEN1KMT2ACYP19A1
SCHEMBL13515570 0.78 EPHX1 (0.40) ALDH1A1EPHX1MEN1KMT2ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025020304-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST AND USE OF CATALYST 中国石油天然气股份有限公司 2025-01-30 WO disclosed
WO-2022078492-A1 MAGNESIUM-BASED SOLID AND CATALYST COMPONENT HAVING MULTIMODAL PORE DISTRIBUTION, AND PREPARATION METHODS THEREFOR 中国石油化工股份有限公司 2022-04-21 WO disclosed
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2019-06-06 US disclosed
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2017-12-14 US disclosed
CN-103214601-A Self-limiting catalyst composition with no silane DOW GLOBAL TECHNOLOGIES INC (US) 2013-07-24 CN disclosed
CN-101835813-B Silane-free self-limiting catalyst composition DOW GLOBAL TECHNOLOGIES INC (US) 2013-04-17 CN disclosed
CN-101835813-A Silane-free self-limiting catalyst composition DOW GLOBAL TECHNOLOGIES INC (US) 2010-09-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, GTF2I, POF1B ALDH1A1 2055/4885EPHX1 3610/4885MEN1 452/4885
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, COG7, COG4 ALDH1A1 2496/4885EPHX1 2500/4885MEN1 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.